Axa S.A. Apellis Pharmaceuticals, Inc. Transaction History

Axa S.A.

$32.3 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$76.68 - $93.31 $182,958 - $222,637	2,386 Added 1.39%	173,495 $15.8 Million
Q1 2023 May 15, 2023	BUY	$46.59 - $66.96 $1.18 Million - $1.7 Million	25,405 Added 17.44%	171,109 $11.3 Million
Q4 2022 Feb 14, 2023	SELL	$43.24 - $61.04 $33,900 - $47,855	-784 Reduced 0.54%	145,704 $7.53 Million
Q3 2022 Feb 14, 2023	BUY	$44.76 - $69.66 $3.05 Million - $4.75 Million	68,183 Added 87.07%	146,488 $10 Million
Q3 2022 Nov 14, 2022	BUY	$44.76 - $69.66 $3.05 Million - $4.75 Million	68,183 Added 87.07%	146,488 $10 Million
Q2 2022 Feb 14, 2023	SELL	$35.07 - $59.21 $2.39 Million - $4.04 Million	-68,183 Reduced 46.55%	78,305 $3.54 Million
Q2 2022 Aug 15, 2022	BUY	$35.07 - $59.21 $2.75 Million - $4.64 Million	78,305 New	78,305 $3.54 Million
Q3 2021 Nov 15, 2021	SELL	$31.4 - $69.84 $1.3 Million - $2.89 Million	-41,321 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$40.9 - $64.9 $128,426 - $203,786	-3,140 Reduced 7.06%	41,321 $2.61 Million
Q1 2021 May 14, 2021	SELL	$40.8 - $57.39 $6.8 Million - $9.56 Million	-166,647 Reduced 78.94%	44,461 $1.91 Million
Q4 2020 Feb 12, 2021	BUY	$30.79 - $57.2 $667,557 - $1.24 Million	21,681 Added 11.45%	211,108 $12.1 Million
Q3 2020 Nov 13, 2020	BUY	$25.89 - $33.65 $486,550 - $632,384	18,793 Added 11.01%	189,427 $5.72 Million
Q2 2020 Aug 14, 2020	BUY	$24.8 - $38.49 $251,546 - $390,404	10,143 Added 6.32%	170,634 $5.57 Million
Q1 2020 May 15, 2020	BUY	$17.91 - $44.33 $1.19 Million - $2.93 Million	66,200 Added 70.21%	160,491 $4.3 Million
Q4 2019 Feb 18, 2020	BUY	$22.1 - $30.8 $2.08 Million - $2.9 Million	94,291 New	94,291 $2.89 Million

Others Institutions Holding APLS

# of Institutions

310

Shares Held

113M

Call Options Held

3.85M

Put Options Held

1.09M

Wellington Management Group LLP Boston, MA

15.6M
Shares

$466 Million
0.08% of portfolio
Eco R1 Capital, LLC San Francisco, CA

11.9M
Shares

$356 Million
14.88% of portfolio
Avoro Capital Advisors LLC New York, NY

11.1M
Shares

$333 Million
4.82% of portfolio
Vanguard Group Inc Valley Forge, PA

9.82M
Shares

$294 Million
0.01% of portfolio
Black Rock Inc. New York, NY

5.8M
Shares

$174 Million
0.01% of portfolio

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.29B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account